ʻO ka pauka Semaglutide
| inoa maʻamau: | Semaglutide |
| Ka helu helu: | 910463-68-2 |
| ʻAno Molekala: | C187H291N45O59 |
| kaumaha molekala: | 4113.641 g/mol |
| Kaʻina: | -His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17 -carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH |
| ʻAno: | Pauda keʻokeʻo |
| Noi: | ʻO Semaglutide kahi lāʻau lapaʻau i hoʻohana ʻia e mālama i ka maʻi diabetes type 2. Aia ia i kahi papa o nā lāʻau i kapa ʻia ʻo GLP-1 receptor agonists, e hana ana ma ka hoʻonui ʻana i ka huna ʻana o ka insulin a me ka hoʻemi ʻana i ka hana glucose i loko o ke ake. Hoʻokomo ʻia ʻo Semaglutide i hoʻokahi manawa i ka pule a ua hōʻike ʻia i nā hoʻokolohua lapaʻau e hoʻohaʻahaʻa pono i ke kō koko koko. Eia kekahi, ua pili pū me ka pohō kaumaha a hoʻomaikaʻi i nā hopena cardiovascular. Hoʻomaʻamaʻa maikaʻi ʻia ʻo Semaglutide, akā hiki i kekahi poʻe maʻi ke loaʻa i nā hopena ʻaoʻao e like me ka nausea, ka luaʻi a i ʻole ka maʻi maʻi. Pono nā poʻe maʻi e kūkākūkā i nā hopena ʻaoʻao āpau a me nā pilikia me kā lākou mea mālama ola ma mua o ka lawe ʻana i ka semaglutide. He mea nui e hoʻomaopopo ʻaʻole pono e hoʻohana ʻia ka semaglutide e mālama i ka maʻi diabetes type 1 a i ʻole ketoacidosis diabetic. |
| Pūʻolo: | ʻeke alumini alumini a i ʻole alumini TIN a i ʻole e like me nā koi o ka mea kūʻai aku |
| 1 | Mea hoʻolako ʻoihana no nā API peptide mai Kina. |
| 2 | 16 laina hana me ka nui o ka mana hana me ka uku hoʻokūkū |
| 3 | Loaʻa ka GMP a me DMF me nā palapala hilinaʻi loa. |
A: ʻAe, hiki iā mākou ke hoʻopili e like me kāu koi.
A: ʻO ka ʻike LC a me ka TT ma mua o ka manawa uku i makemake ʻia.
A: ʻAe, e ʻoluʻolu e hāʻawi i kāu kikoʻī maikaʻi, e nānā mākou me kā mākou R&D a hoʻāʻo e hoʻohālikelike i kāu kikoʻī maikaʻi.
E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou
